Alcohol and Other Psychoactive Substances in Road Traffic - a Case-control Study

NCT ID: NCT00570518

Last Updated: 2011-10-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

4500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-09-30

Study Completion Date

2011-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main purpose of the study is to determine the accident risk when driving under the influence of psychoactive substances, including alcohol (DUI). Other aims are to find out the prevalence of psychoactive substances in road traffic and to obtain information on the role of these substances in road traffic accident causations.

For the purposes of the study, drivers of motorised vehicles are randomly stopped and interviewed and breath alcohol is recorded. Also, an oral fluid sample is taken and psychoactive substances are investigated in the laboratory. For cases, drivers injured in traffic accidents are asked to participate to the study. A whole blood sample and, if possible, an oral fluid sample is taken and psychoactive substances are determined in the laboratory. Also, people diseased in road traffic accident are included in the study. The information required for these subjects are taken from a register database.

The study is part of an EU-project DRUID. Altogether 13 European countries take part to the study.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Prevalence of Psychoactive Substances in Road Traffic Psychoactive Substances in Accident Involved Drivers Relative Risk Estimation of Accident Involvement for Impaired Drivers

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

randomly stopped drivers of motorised vehicles and bicycles

No interventions assigned to this group

2

drivers of motorised vehicles and bicycles injured or killed in road traffic accidents

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years or older
* driver of a motorised vehicle or bicycle
* is willing to participate to the study (not applicable to the diseased drivers; information obtained from a register database)

Exclusion Criteria

* 17 or younger
* not the driver of a motorised vehicle or bicycle
* does not want to participate (not applicable to the diseased drivers; information obtained from a register database)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospital District of Helsinki and Uusimaa

OTHER

Sponsor Role collaborator

European Commission

OTHER

Sponsor Role collaborator

Finnish Institute for Health and Welfare

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pirjo Lillsunde, Dr

Role: PRINCIPAL_INVESTIGATOR

National Public Health Institute

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

National Public Health Institute

Helsinki, , Finland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Finland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Pirjo Lillsunde, Dr

Role: CONTACT

+358947448342

Charlotta Engblom, M.Sc.(Tech.)

Role: CONTACT

+358947448546

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Pirjo Lillsunde, Dr

Role: primary

+358947448342

Charlotta Engblom, M.Sc.(Tech.)

Role: backup

+358947448546

Related Links

Access external resources that provide additional context or updates about the study.

http://www.druid-project.eu

The official homepage of the EU-project

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

404-3

Identifier Type: -

Identifier Source: secondary_id

405-9

Identifier Type: -

Identifier Source: secondary_id

406-5

Identifier Type: -

Identifier Source: secondary_id

KTL 403-2

Identifier Type: -

Identifier Source: org_study_id